Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
IRadimed Corporation is a medical devices business based in the US. IRadimed Corporation shares (IRMD) are listed on the NASDAQ and all prices are listed in US Dollars. IRadimed Corporation employs 110 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $38.16 |
|---|---|
| 52-week range | $21.65 - $50.88 |
| 50-day moving average | $43.78 |
| 200-day moving average | $34.96 |
| Wall St. target price | $41.00 |
| PE ratio | 82.0833 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $0.48 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $38.16 from 2022-01-25
| 1 week (2022-01-19) | -4.17% |
|---|---|
| 1 month (2021-12-23) | -16.90% |
| 3 months (2021-10-26) | 7.28% |
| 6 months (2021-07-26) | 9.66% |
| 1 year (2021-01-26) | 65.91% |
|---|---|
| 2 years (2020-01-24) | 47.85% |
| 3 years (2019-01-25) | 48.14% |
| 5 years (2017-01-26) | 319.34% |
Valuing IRadimed Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of IRadimed Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
IRadimed Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 82x. In other words, IRadimed Corporation shares trade at around 82x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
IRadimed Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.46. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into IRadimed Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
IRadimed Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $14.2 million.
The EBITDA is a measure of a IRadimed Corporation's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $38.5 million |
|---|---|
| Operating margin TTM | 33.41% |
| Gross profit TTM | $23.6 million |
| Return on assets TTM | 10.8% |
| Return on equity TTM | 9.44% |
| Profit margin | 15.77% |
| Book value | $5.50 |
| Market capitalisation | $486.3 million |
TTM: trailing 12 months
We're not expecting IRadimed Corporation to pay a dividend over the next 12 months.
Over the last 12 months, IRadimed Corporation's shares have ranged in value from as little as $21.65 up to $50.878. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while IRadimed Corporation's is 0.8474. This would suggest that IRadimed Corporation's shares are less volatile than average (for this exchange).
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida. .
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Everything we know about the Austin Gold IPO, plus information on how to buy in.
Everything we know about the VinFast IPO, plus information on how to buy in.
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.